226 related articles for article (PubMed ID: 22892136)
1. Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence.
Prieto R; Pascual JM; Subhi-Issa I; Jorquera M; Yus M; Martínez R
World Neurosurg; 2013; 79(5-6):733-49. PubMed ID: 22892136
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
[TBL] [Abstract][Full Text] [Related]
3. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series.
Mortini P; Losa M; Pozzobon G; Barzaghi R; Riva M; Acerno S; Angius D; Weber G; Chiumello G; Giovanelli M
J Neurosurg; 2011 May; 114(5):1350-9. PubMed ID: 21214336
[TBL] [Abstract][Full Text] [Related]
4. Infundibulo-tuberal or not strictly intraventricular craniopharyngioma: evidence for a major topographical category.
Pascual JM; Prieto R; Carrasco R
Acta Neurochir (Wien); 2011 Dec; 153(12):2403-25; discussion 2426. PubMed ID: 21918833
[TBL] [Abstract][Full Text] [Related]
5. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
Weiner HL; Wisoff JH; Rosenberg ME; Kupersmith MJ; Cohen H; Zagzag D; Shiminski-Maher T; Flamm ES; Epstein FJ; Miller DC
Neurosurgery; 1994 Dec; 35(6):1001-10; discussion 1010-1. PubMed ID: 7885544
[TBL] [Abstract][Full Text] [Related]
6. Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors.
Prieto R; Pascual JM; Rosdolsky M; Castro-Dufourny I; Carrasco R; Strauss S; Barrios L
Neurosurg Focus; 2016 Dec; 41(6):E13. PubMed ID: 27903121
[TBL] [Abstract][Full Text] [Related]
7. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors.
Kim SK; Wang KC; Shin SH; Choe G; Chi JG; Cho BK
Childs Nerv Syst; 2001 Sep; 17(9):531-6; discussion 537. PubMed ID: 11585327
[TBL] [Abstract][Full Text] [Related]
8. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
Niu DM; Guo WY; Pan HC; Wong TT
Childs Nerv Syst; 2002 Apr; 18(3-4):164-5. PubMed ID: 11981627
[TBL] [Abstract][Full Text] [Related]
9. Malignant Transformation of Radiotherapy-Naïve Craniopharyngioma.
Chunhui L; Chuzhong L; Zhenye L; Yilin S; Yazhuo Z
World Neurosurg; 2016 Apr; 88():690.e1-690.e5. PubMed ID: 26654928
[TBL] [Abstract][Full Text] [Related]
10. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients.
Pan J; Qi S; Liu Y; Lu Y; Peng J; Zhang X; Xu Y; Huang GL; Fan J
J Neurosurg Pediatr; 2016 Apr; 17(4):418-33. PubMed ID: 26636252
[TBL] [Abstract][Full Text] [Related]
11. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.
Duò D; Gasverde S; Benech F; Zenga F; Giordana MT
Clin Neuropathol; 2003; 22(5):229-34. PubMed ID: 14531547
[TBL] [Abstract][Full Text] [Related]
12. Primary suprasellar malignant tumor with odontogenic features: case report.
Nishioka H; Shibuya M; Izawa H; Ikeda Y
Neurosurgery; 2009 Aug; 65(2):E380-2; discussion E382. PubMed ID: 19625894
[TBL] [Abstract][Full Text] [Related]
13. Papillary Craniopharyngioma: A Type of Tumor Primarily Impairing the Hypothalamus - A Comprehensive Anatomo-Clinical Characterization of 350 Well-Described Cases.
Prieto R; Barrios L; Pascual JM
Neuroendocrinology; 2022; 112(10):941-965. PubMed ID: 35108706
[TBL] [Abstract][Full Text] [Related]
14. Recurrent craniopharyngioma with nasopharyngeal extension.
Taguchi Y; Tanaka K; Miyakita Y; Sekino H; Fujimoto M
Pediatr Neurosurg; 2000 Mar; 32(3):140-4. PubMed ID: 10867561
[TBL] [Abstract][Full Text] [Related]
15. The transsphenoidal resection of pediatric craniopharyngiomas: a case series.
Jane JA; Prevedello DM; Alden TD; Laws ER
J Neurosurg Pediatr; 2010 Jan; 5(1):49-60. PubMed ID: 20043736
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the levels of expression of retinoic acid receptors, galectin-3, macrophage migration inhibiting factor, and p53 in 51 adamantinomatous craniopharyngiomas.
Lefranc F; Chevalier C; Vinchon M; Dhellemmes P; Schüring MP; Kaltner H; Brotchi J; Ruchoux MM; Gabius HJ; Salmon I; Kiss R
J Neurosurg; 2003 Jan; 98(1):145-53. PubMed ID: 12546363
[TBL] [Abstract][Full Text] [Related]
17. The infundibulo-tuberal syndrome caused by craniopharyngiomas: clinicopathological evidence from an historical French cohort (1705-1973).
Castro-Dufourny I; Carrasco R; Prieto R; Barrios L; Pascual JM
Pituitary; 2015 Oct; 18(5):642-57. PubMed ID: 25527245
[TBL] [Abstract][Full Text] [Related]
18. Ectopic recurrence of craniopharyngiomas: case report.
Bikmaz K; Guerrero CA; Dammers R; Krisht AF; Husain MM
Neurosurgery; 2009 Feb; 64(2):E382-3; discussion E383. PubMed ID: 19190442
[TBL] [Abstract][Full Text] [Related]
19. Immune Microenvironment of Primary and Recurrent Craniopharyngiomas: A Study of the Differences and Clinical Significance.
Lin D; Wang Y; Zhou Z; Lin Z
World Neurosurg; 2019 Jul; 127():e212-e220. PubMed ID: 30880197
[TBL] [Abstract][Full Text] [Related]
20. Postoperative intracranial seeding of craniopharyngiomas--report of three cases and review of the literature.
Schmalisch K; Beschorner R; Psaras T; Honegger J
Acta Neurochir (Wien); 2010 Feb; 152(2):313-9; discussion 319. PubMed ID: 19859655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
